Pyxis Oncology Statistics

Total Valuation

Pyxis Oncology has a market cap or net worth of $68.76 million. The enterprise value is -$16.83 million.

Market Cap	68.76M
Enterprise Value	-16.83M

Important Dates

The last earnings date was Thursday, May 15, 2025, before market open.

Earnings Date	May 15, 2025
Ex-Dividend Date	n/a

Share Statistics

Pyxis Oncology has 61.95 million shares outstanding. The number of shares has increased by 38.73% in one year.

Current Share Class	61.95M
Shares Outstanding	61.95M
Shares Change (YoY)	+38.73%
Shares Change (QoQ)	-0.32%
Owned by Insiders (%)	6.29%
Owned by Institutions (%)	32.69%
Float	44.65M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.66
P/TBV Ratio	0.68
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 7.75, with a Debt / Equity ratio of 0.19.

Current Ratio	7.75
Quick Ratio	7.31
Debt / Equity	0.19
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -66.30% and return on invested capital (ROIC) is -31.70%.

Return on Equity (ROE)	-66.30%
Return on Assets (ROA)	-29.19%
Return on Invested Capital (ROIC)	-31.70%
Return on Capital Employed (ROCE)	-68.48%
Revenue Per Employee	n/a
Profits Per Employee	-$2.16M
Employee Count	44
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-2.16M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -73.57% in the last 52 weeks. The beta is 1.15, so Pyxis Oncology's price volatility has been higher than the market average.

Beta (5Y)	1.15
52-Week Price Change	-73.57%
50-Day Moving Average	1.06
200-Day Moving Average	2.28
Relative Strength Index (RSI)	51.79
Average Volume (20 Days)	564,644

Short Selling Information

The latest short interest is 7.23 million, so 11.68% of the outstanding shares have been sold short.

Short Interest	7.23M
Short Previous Month	7.13M
Short % of Shares Out	11.68%
Short % of Float	16.20%
Short Ratio (days to cover)	13.60

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-83.16M
Pretax Income	-57.80M
Net Income	-95.23M
EBITDA	-80.55M
EBIT	-83.16M
Earnings Per Share (EPS)	-$1.57

Full Income Statement

Balance Sheet

The company has $105.43 million in cash and $19.84 million in debt, giving a net cash position of $85.59 million or $1.38 per share.

Cash & Cash Equivalents	105.43M
Total Debt	19.84M
Net Cash	85.59M
Net Cash Per Share	$1.38
Equity (Book Value)	103.10M
Book Value Per Share	1.69
Working Capital	97.44M

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Pyxis Oncology does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-38.73%
Shareholder Yield	-38.73%
Earnings Yield	-138.50%
FCF Yield	n/a

Analyst Forecast

The average price target for Pyxis Oncology is $9.00, which is 710.81% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$9.00
Price Target Difference	710.81%
Analyst Consensus	Strong Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	40.82%
EPS Growth Forecast (5Y)	-3.11%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a